Back to Search Start Over

Supplementary Figure 3 from Oncolytic Immunotherapy of Advanced Solid Tumors with a CD40L-Expressing Replicating Adenovirus: Assessment of Safety and Immunologic Responses in Patients

Authors :
Akseli Hemminki
Vincenzo Cerullo
Tuomo Alanko
Tima Joensuu
Leena Laasonen
Kaarina P. L. Partanen
Satu Kauppinen
Aila Karioja-Kallio
Sirkka-Liisa Holm
Elina Haavisto
Minna Oksanen
Kalevi Kairemo
Ann M. Leen
Ulrike Gerdemann
Saila K. Pesonen
Anna Kanerva
Tuuli Ranki
Lotta Kangasniemi
Iulia Diaconu
Sari Pesonen
Publication Year :
2023
Publisher :
American Association for Cancer Research (AACR), 2023.

Abstract

PDF file - 1.1MB, (A) Patient serum samples were analyzed for Th1 induced cytokines interferon-� (IFN-�), tumor necrosis factor-� (TNF-�) and interleukin-2 (IL-2) and Th2 cytokines interleukin-4 (IL-4), interleukin-5 (IL-5) and Interleukin 10 (IL-10). The ratio between Th1 and Th2 type cytokines was assessed. Cytokines levels are reported relative to their baseline level, which was set as 1 and a ratio between Th1/Th2 was calculated for each time point. (B) Malignant ascites of patient R8 and pleural effusion of patient T181 were analyzed for Th1 induced cytokines IFN-� and IL-2, and for Th2 induced IL-10 before and after treatment.

Details

Database :
OpenAIRE
Accession number :
edsair.doi.dedup.....60e3f2297d82c95406a5e0085de07c67
Full Text :
https://doi.org/10.1158/0008-5472.22392483.v1